These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

717 related articles for article (PubMed ID: 37371099)

  • 1. Clinical Significance of MicroRNAs, Long Non-Coding RNAs, and CircRNAs in Cardiovascular Diseases.
    Singh DD; Kim Y; Choi SA; Han I; Yadav DK
    Cells; 2023 Jun; 12(12):. PubMed ID: 37371099
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circular RNAs as a Diagnostic and Therapeutic Target in Cardiovascular Diseases.
    Joaquim VHA; Pereira NP; Fernandes T; Oliveira EM
    Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768449
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Non-Coding RNA-Mediated Gene Regulation in Cardiovascular Disorders: Current Insights and Future Directions.
    Abubakar M; Hajjaj M; Naqvi ZEZ; Shanawaz H; Naeem A; Padakanti SSN; Bellitieri C; Ramar R; Gandhi F; Saleem A; Abdul Khader AHS; Faraz MA
    J Cardiovasc Transl Res; 2024 Aug; 17(4):739-767. PubMed ID: 38092987
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long noncoding RNA/circular noncoding RNA-miRNA-mRNA axes in cardiovascular diseases.
    Li M; Duan L; Li Y; Liu B
    Life Sci; 2019 Sep; 233():116440. PubMed ID: 31047893
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circular noncoding RNAs as potential therapies and circulating biomarkers for cardiovascular diseases.
    Bayoumi AS; Aonuma T; Teoh JP; Tang YL; Kim IM
    Acta Pharmacol Sin; 2018 Jul; 39(7):1100-1109. PubMed ID: 29565037
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Non-coding RNAs and angiogenesis in cardiovascular diseases: a comprehensive review.
    Zhang J
    Mol Cell Biochem; 2024 Nov; 479(11):2921-2953. PubMed ID: 38306012
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comprehensive review for non-coding RNAs: From mechanisms to therapeutic applications.
    Zhang Y; Zhan L; Jiang X; Tang X
    Biochem Pharmacol; 2024 Jun; 224():116218. PubMed ID: 38643906
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ncRNAs and polyphenols: new therapeutic strategies for hypertension.
    Shirazi-Tehrani E; Chamasemani A; Firouzabadi N; Mousaei M
    RNA Biol; 2022; 19(1):575-587. PubMed ID: 35438046
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Non-coding RNAs regulating mitochondrial function in cardiovascular diseases.
    Ao X; Ding W; Li X; Xu Q; Chen X; Zhou X; Wang J; Liu Y
    J Mol Med (Berl); 2023 May; 101(5):501-526. PubMed ID: 37014377
    [TBL] [Abstract][Full Text] [Related]  

  • 10. From molecules to heart regeneration: Understanding the complex and profound role of non-coding RNAs in stimulating cardiomyocyte proliferation for cardiac repair.
    Alissa M; Aldurayhim M; Abdulaziz O; Alsalmi O; Awad A; Algopishi UB; Alharbi S; Safhi AY; Khan KH; Uffar C
    Curr Probl Cardiol; 2024 Dec; 49(12):102857. PubMed ID: 39306148
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-coding RNAs: key players in cardiac disease.
    Kreutzer FP; Fiedler J; Thum T
    J Physiol; 2020 Jul; 598(14):2995-3003. PubMed ID: 31291008
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Noncoding RNAs in Cardiac Hypertrophy and Heart Failure.
    Lu P; Ding F; Xiang YK; Hao L; Zhao M
    Cells; 2022 Feb; 11(5):. PubMed ID: 35269399
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Non-coding RNAs in disease: from mechanisms to therapeutics.
    Nemeth K; Bayraktar R; Ferracin M; Calin GA
    Nat Rev Genet; 2024 Mar; 25(3):211-232. PubMed ID: 37968332
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Noncoding RNAs in age-related cardiovascular diseases.
    Jusic A; Thomas PB; Wettinger SB; Dogan S; Farrugia R; Gaetano C; Tuna BG; Pinet F; Robinson EL; Tual-Chalot S; Stellos K; Devaux Y;
    Ageing Res Rev; 2022 May; 77():101610. PubMed ID: 35338919
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Non-coding RNAs in cardiovascular diseases: diagnostic and therapeutic perspectives.
    Poller W; Dimmeler S; Heymans S; Zeller T; Haas J; Karakas M; Leistner DM; Jakob P; Nakagawa S; Blankenberg S; Engelhardt S; Thum T; Weber C; Meder B; Hajjar R; Landmesser U
    Eur Heart J; 2018 Aug; 39(29):2704-2716. PubMed ID: 28430919
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systematic review regulatory principles of non-coding RNAs in cardiovascular diseases.
    Li Y; Huo C; Pan T; Li L; Jin X; Lin X; Chen J; Zhang J; Guo Z; Xu J; Li X
    Brief Bioinform; 2019 Jan; 20(1):66-76. PubMed ID: 28968629
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Strategies and challenges for non-viral delivery of non-coding RNAs to the heart.
    Vilaça A; de Windt LJ; Fernandes H; Ferreira L
    Trends Mol Med; 2023 Jan; 29(1):70-91. PubMed ID: 36371335
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Non-Coding RNAs in Neurological and Neuropsychiatric Disorders: Unraveling the Hidden Players in Disease Pathogenesis.
    Ilieva MS
    Cells; 2024 Jun; 13(12):. PubMed ID: 38920691
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting non-coding RNAs to overcome cancer therapy resistance.
    Chen B; Dragomir MP; Yang C; Li Q; Horst D; Calin GA
    Signal Transduct Target Ther; 2022 Apr; 7(1):121. PubMed ID: 35418578
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Role and Molecular Mechanism of Non-Coding RNAs in Pathological Cardiac Remodeling.
    Gao J; Xu W; Wang J; Wang K; Li P
    Int J Mol Sci; 2017 Mar; 18(3):. PubMed ID: 28287427
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 36.